The American Association for Cancer Research (AACR) and the Society for Immunotherapy of Cancer (SITC) will co-host a congressional briefing titled, “Progress in Immunotherapy: Delivering Hope and Clinical Benefit to Cancer Patients,” to highlight innovations in the field of immunotherapy, illustrate the hope that these advances are bringing to patients, and note the challenges that need to be overcome so that even more patients can benefit from these revolutionary treatments.
For many patients, cancer immunotherapies are providing lifesaving results where other treatments had failed or were not viable. But realizing more breakthroughs in this area and increasing the number of types of cancers that can be treated with immunotherapy requires a sustained, federal investment in cancer research through the National Institutes of Health and the National Cancer Institute.
WHEN/WHERE:
Wednesday, July 19, noon-1:30pm ET
Russell Senate Office Building, Room 485 on Capitol Hill in Washington, D.C.
Speakers include:
-
Elizabeth M. Jaffee, M.D., AACR President-Elect 2017-2018; Chair, National Cancer Institute’s National Cancer Advisory Board; Member, Biden Cancer Initiative Board of Directors; Deputy Director,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore
-
Lisa H. Butterfield, Ph.D., President, SITC; Professor of Medicine, Surgery and Immunology; and Director, UPCI Immunologic Monitoring and Cellular Products Laboratory, University of Pittsburgh
-
Steven A. Rosenberg, M.D., Ph.D., Chief of Surgery, National Cancer Institute, Bethesda, Maryland
-
Bernard A. Fox, Ph.D., Past President, SITC; Chief, Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, Oregon
-
Daniel S. Chen, M.D., Ph.D., Vice President, Global Head of Cancer Immunotherapy Development, Genentech, South San Francisco
-
Stefanie Joho, colon cancer survivor who benefited from immunotherapy
How to Attend:
To attend, please RSVP to Rachel Salis-Silverman at rachel.silverman@aacr.org or 215-446-7159. Visit the newsroom.